Launched in Spain and Colombia in 2020, myBIOME is an innovative gut microbiome examination based on technology developed by Microba’s leading researchers in the field of microbiome analysis. The ...

PARIS--(BUSINESS WIRE)--Regulatory News: Ikonisys (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for ...

International private equity firm, Cinven, has reached an agreement to sell an indirect minority stake in SYNLAB, a leader in medical diagnostic services and specialty testing in Europe, to strategic ...

Cinven agreed to buy out Synlab AG for about €1.27 billion ($1.3 billion) two years after listing the German laboratory operator, which has been suffering from reduced demand for its testing ...

EDIT-B™: a reliable, validated and rapid biological response to reduce the diagnostic delay and address an unmet medical need. ALCEDIAG and SYNLAB are making EDIT-B™ , based on RNA editing and AI, ...

Cinven has made an indicative offer to take Synlab AG private in a roughly €2.2 billion ($2.4 billion) deal, just two years after listing the German laboratory operator that’s now battling with ...

(Reuters) – Buyout group BC Partners has put German laboratory operator Synlab up for sale in a potential deal worth more than 1.5 billion euros ($1.6 billion), three people familiar with the matter ...

Buyout fund Cinven has launched preparations for a potential stock market listing of German laboratory services group Synlab, while also sounding out potential buyers for a 5.5 billion euro ($6 ...